Orion Oyj (OTCMKTS:ORINF) Short Interest Update

Orion Oyj (OTCMKTS:ORINF) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 623,300 shares, a growth of 24.9% from the February 13th total of 498,900 shares. Based on an average daily volume of 300 shares, the short-interest ratio is presently 2,077.7 days.

Orion Oyj Stock Performance

Shares of OTCMKTS:ORINF remained flat at $48.65 during trading on Monday. Orion Oyj has a one year low of $48.65 and a one year high of $48.65. The firm has a fifty day simple moving average of $48.65 and a 200 day simple moving average of $47.97.

Orion Oyj Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.